Search Articles

Home / Articles

The Neurophysiological Changes by Nerve Conduction Study and Electromyography in Acute and Long-Term COVID-19 Circumstances: A Comparative Study Protocol and Review

. Nareen Haikaz Hasrat , Haithem Jawad Kadhum , Ali Raheem Hashim , Zaineb Adil Yaqoob, Lana Ahmed Kadhum and Hassan Ala Farid


Abstract

In December 2019, a new disease called Novel Coronavirus Disease or COVID-19, caused by the virus SARS CoV-2, started in Wuhan, China and was spreading around the world with pneumonia-like symptoms. Many people infected with COVID-19 have been diagnosed with typical Guillain-Barré syndrome (GBS) or its variants, as well as other demyelinating neuropathies. Furthermore, there is an increase in critical illness neuropathy (axonopathy) and myopathy during acute COVID-19 and post-COVID-19 periods. As a result, it is critical to raise awareness about COVID-19-related neuropathy and myopathy, as well as to provide a simple and practical method for diagnosing and following up on patients using electromyography (EMG) and nerve conduction studies (NCS) to evaluate neuro-electrophysiological changes in COVID-19 patients in acute and long-term settings. Therefore, an analytical, comparative cross-sectional study will be held in Basra City, southern Iraq, focusing on acute and chronic demyelinating neuropathy, critical illness axonopathy, inflammatory myopathy, and long-standing myopathy that accompany or follow COVID-19 infection. 

 

Index Terms- EMG, Neurophysiology, COVID-19, Neuropathy, Myopathy, GBS

Download :